Cargando…

Blood-Brain Barrier Impairment in an Animal Model of MPS III B

BACKGROUND: Sanfilippo syndrome type B (MPS III B) is caused by a deficiency of α-N-acetylglucosaminidase enzyme, leading to accumulation of heparan sulfate within lysosomes and eventual progressive cerebral and systemic multiple organ abnormalities. However, little is known about the competence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Garbuzova-Davis, Svitlana, Louis, Michael K., Haller, Edward M., Derasari, Hiranya M., Rawls, Ashley E., Sanberg, Paul R.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049764/
https://www.ncbi.nlm.nih.gov/pubmed/21408219
http://dx.doi.org/10.1371/journal.pone.0016601
_version_ 1782199269356208128
author Garbuzova-Davis, Svitlana
Louis, Michael K.
Haller, Edward M.
Derasari, Hiranya M.
Rawls, Ashley E.
Sanberg, Paul R.
author_facet Garbuzova-Davis, Svitlana
Louis, Michael K.
Haller, Edward M.
Derasari, Hiranya M.
Rawls, Ashley E.
Sanberg, Paul R.
author_sort Garbuzova-Davis, Svitlana
collection PubMed
description BACKGROUND: Sanfilippo syndrome type B (MPS III B) is caused by a deficiency of α-N-acetylglucosaminidase enzyme, leading to accumulation of heparan sulfate within lysosomes and eventual progressive cerebral and systemic multiple organ abnormalities. However, little is known about the competence of the blood-brain barrier (BBB) in MPS III B. BBB dysfunction in this devastating disorder could contribute to neuropathological disease manifestations. METHODOLOGY/PRINCIPAL FINDINGS: In the present study, we investigated structural (electron microscope) and functional (vascular leakage) integrity of the BBB in a mouse model of MPS III B at different stages of disease, focusing on brain structures known to experience neuropathological changes. Major findings of our study were: (1) endothelial cell damage in capillary ultrastructure, compromising the BBB and resulting in vascular leakage, (2) formation of numerous large vacuoles in endothelial cells and perivascular cells (pericytes and perivascular macrophages) in the large majority of vessels, (3) edematous space around microvessels, (4) microaneurysm adjacent to a ruptured endothelium, (6) Evans Blue and albumin microvascular leakage in various brain structures, (7) GM3 ganglioside accumulation in endothelium of the brain microvasculature. CONCLUSIONS/SIGNIFICANCE: These new findings of BBB structural and function impairment in MPS III B mice even at early disease stage may have implications for disease pathogenesis and should be considered in current and future development of treatments for MPS III B.
format Text
id pubmed-3049764
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-30497642011-03-15 Blood-Brain Barrier Impairment in an Animal Model of MPS III B Garbuzova-Davis, Svitlana Louis, Michael K. Haller, Edward M. Derasari, Hiranya M. Rawls, Ashley E. Sanberg, Paul R. PLoS One Research Article BACKGROUND: Sanfilippo syndrome type B (MPS III B) is caused by a deficiency of α-N-acetylglucosaminidase enzyme, leading to accumulation of heparan sulfate within lysosomes and eventual progressive cerebral and systemic multiple organ abnormalities. However, little is known about the competence of the blood-brain barrier (BBB) in MPS III B. BBB dysfunction in this devastating disorder could contribute to neuropathological disease manifestations. METHODOLOGY/PRINCIPAL FINDINGS: In the present study, we investigated structural (electron microscope) and functional (vascular leakage) integrity of the BBB in a mouse model of MPS III B at different stages of disease, focusing on brain structures known to experience neuropathological changes. Major findings of our study were: (1) endothelial cell damage in capillary ultrastructure, compromising the BBB and resulting in vascular leakage, (2) formation of numerous large vacuoles in endothelial cells and perivascular cells (pericytes and perivascular macrophages) in the large majority of vessels, (3) edematous space around microvessels, (4) microaneurysm adjacent to a ruptured endothelium, (6) Evans Blue and albumin microvascular leakage in various brain structures, (7) GM3 ganglioside accumulation in endothelium of the brain microvasculature. CONCLUSIONS/SIGNIFICANCE: These new findings of BBB structural and function impairment in MPS III B mice even at early disease stage may have implications for disease pathogenesis and should be considered in current and future development of treatments for MPS III B. Public Library of Science 2011-03-07 /pmc/articles/PMC3049764/ /pubmed/21408219 http://dx.doi.org/10.1371/journal.pone.0016601 Text en Garbuzova-Davis et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Garbuzova-Davis, Svitlana
Louis, Michael K.
Haller, Edward M.
Derasari, Hiranya M.
Rawls, Ashley E.
Sanberg, Paul R.
Blood-Brain Barrier Impairment in an Animal Model of MPS III B
title Blood-Brain Barrier Impairment in an Animal Model of MPS III B
title_full Blood-Brain Barrier Impairment in an Animal Model of MPS III B
title_fullStr Blood-Brain Barrier Impairment in an Animal Model of MPS III B
title_full_unstemmed Blood-Brain Barrier Impairment in an Animal Model of MPS III B
title_short Blood-Brain Barrier Impairment in an Animal Model of MPS III B
title_sort blood-brain barrier impairment in an animal model of mps iii b
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049764/
https://www.ncbi.nlm.nih.gov/pubmed/21408219
http://dx.doi.org/10.1371/journal.pone.0016601
work_keys_str_mv AT garbuzovadavissvitlana bloodbrainbarrierimpairmentinananimalmodelofmpsiiib
AT louismichaelk bloodbrainbarrierimpairmentinananimalmodelofmpsiiib
AT halleredwardm bloodbrainbarrierimpairmentinananimalmodelofmpsiiib
AT derasarihiranyam bloodbrainbarrierimpairmentinananimalmodelofmpsiiib
AT rawlsashleye bloodbrainbarrierimpairmentinananimalmodelofmpsiiib
AT sanbergpaulr bloodbrainbarrierimpairmentinananimalmodelofmpsiiib